Literature DB >> 18456726

The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.

Motoyuki Iemitsu1, Nobutake Shimojo, Seiji Maeda, Yoko Irukayama-Tomobe, Satoshi Sakai, Takeshi Ohkubo, Yukihisa Tanaka, Takashi Miyauchi.   

Abstract

The spontaneously hypertensive rat (SHR) is a model of cardiomyopathy that displays a genetic defect in cardiac fatty acid (FA) translocase/CD36, a plasma membrane long-chain FA transporter. Therapy with medium-chain FAs, which do not require CD36-facilitated transport, has been shown to improve cardiac function and hypertrophy in SHRs despite persistent hypertension. However, little is known about the underlying molecular mechanisms. The aim of this study was to document the impact of medium-chain triglyceride (MCT) therapy in SHRs on the expression level and activity of metabolic enzymes and signaling pathways. Four-week-old male SHRs were administered MCT (SHR-MCT) or long-chain triglyceride (SHR-LCT) for 16 wk. We used Wistar-Kyoto (WKY) rats as controls (WKY-MCT and WKY-LCT). The SHR-MCT group displayed improved cardiac dysfunction [as assessed by left ventricular (LV) end-diastolic pressure and the positive and negative first derivatives of LV pressure/P value], a shift in the beta-myosin heavy chain (MHC)-to-alpha-MHC ratio, and cardiac hypertrophy compared with the SHR-LCT group without an effect on blood pressure. Administration of MCT of SHRs reversed the LCT-induced reduction in the cardiac FA metabolic enzymatic activities of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and medium-chain acyl-CoA dehydrogenase (MCAD). In the SHR-MCT group, the protein expression and transcriptional regulation of myocardial peroxisome proliferator-activated receptor-alpha, which regulates the transcription of LCHAD and MCAD genes, corresponded to the changes seen in those enzymatic activities. Furthermore, MCT intake caused an inhibition of JNK activation in SHR hearts. Collectively, the observed changes in the myocardial activity of metabolic enzymes and signaling pathways may contribute to the improved cardiac dysfunction and hypertrophy in SHRs following MCT therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456726     DOI: 10.1152/ajpheart.01417.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.

Authors:  Saifudeen Ismael; Sreeja Purushothaman; V S Harikrishnan; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

2.  Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.

Authors:  Saifudeen Ismael; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2020-09-30       Impact factor: 3.396

3.  In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.

Authors:  Michael S Dodd; Daniel R Ball; Marie A Schroeder; Lydia M Le Page; Helen J Atherton; Lisa C Heather; Anne-Marie Seymour; Houman Ashrafian; Hugh Watkins; Kieran Clarke; Damian J Tyler
Journal:  Cardiovasc Res       Date:  2012-05-16       Impact factor: 10.787

4.  Gene expression profile of muscle adaptation to high-intensity intermittent exercise training in young men.

Authors:  Eri Miyamoto-Mikami; Katsunori Tsuji; Naoki Horii; Natsuki Hasegawa; Shumpei Fujie; Toshiyuki Homma; Masataka Uchida; Takafumi Hamaoka; Hiroaki Kanehisa; Izumi Tabata; Motoyuki Iemitsu
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

5.  Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.

Authors:  Veronique Deschodt-Arsac; Laurent Arsac; Julie Magat; Jerome Naulin; Bruno Quesson; Pierre Dos Santos
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

6.  Hypoketotic hypoglycemia in citrin deficiency: a case report.

Authors:  Yoichi Wada; Natsuko Arai-Ichinoi; Atsuo Kikuchi; Osamu Sakamoto; Shigeo Kure
Journal:  BMC Pediatr       Date:  2020-09-22       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.